Successful Treatment for Lupus Podocytopathy with Prolonged Course of Corticosteroid  by Ho, Elaine T.L. et al.
S56 Lupus Nephropathyhttp://dx.doi.org/10.1016/j.hkjn.2015.08.146
0265
Successful Treatment for Lupus Podocytopathy with Prolonged Course
of Corticosteroid
Elaine T. L. Ho1, Tony K. F. Chau2, Joseph S. Yeung1
1Department of Medicine, Tseung Kwan O Hospital, Hong Kong
2Department of Pathology, Tseung Kwan O Hospital, Hong Kong
Background: Lupus podocytopathy was recently recognized as a distinct en-
tity of lupus nephritis apart from those described in ISN/RPS 2003
classification.
Case Summary: We report a 16-year-old girl who presented with bilateral
lower limb edema and peri-orbital puffiness for 2 weeks. She had no skin
rash, joint pain nor hematuria. She did not take any over-the-counter med-
ications. Her younger sister had biopsy proven lupus nephritis 3 years prior
and was treated with steroid. Laboratory investigations showed proteinuria
7.52 g/d, serum albumin 15.3 g/L, creatinine 51 umol/L, total cholesterol
14.36 mmol/L, ANA titre 1:160, presence of anti-ENA antibody and anti-Ro
antibody, anti-dsDNA >300 IU/ml and C3 0.25 g/L. Renal biopsy showed
diffuse global mesangial hypercellularity with increased mesangial matrix.
There was no endocapillary proliferation and the glomerular basement
membrane was normal. Direct immunofluorescence study showed diffuseglobal mesangial staining for IgG, IgA, IgM, C3 and C1q. Electron microscopy
revealed near-complete effacement of podocytic foot processes with micro-
villous hyperplasia. There were diffuse medium to large mesangial and para-
mesangial immune complex deposits, while only focal scattered small
immune complex deposits were noted in the subendothelial and subepithe-
lial compartment. The diagnosis was class II lupus nephritis with podocytop-
athy. She was treated with high dose prednisolone (1 mg/kg/d) for 4 weeks
and then tapered down slowly. Azathioprine was added in the 5th month as
steroid-sparing agent. She had gradual serological improvement and the pro-
teinuria nearly subsided with normal serum albumin at 14 months.
Conclusion: This case illustrates that lupus podocytopathy can be managed
by prolonged course of corticosteroid. However, further study is required to
investigate the optimal treatment strategy and duration for the condition.http://dx.doi.org/10.1016/j.hkjn.2015.08.147
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Objective: To investigate the influence of persistent hypocomplementemia
on lupus nephritis (LN) activity and prognosis.
Methods: This retrospective study included 39 patients with renal biopsy-
proven active LN [2 of class II, 5 of class III, 17 of class IV, 7 of class V, 2
of class V+III, and 4 of class V+IV; 2 male, 37 female; median age
36.46  11.72 (range 16e68) years, average follow-up 60.18  33.48 (range
24e142) months], and persistent low serum C3 lasting for more than 2 years.
At the initial stage, 17 of 39 (43.59%) had nephrotic proteinuria (> 3.5 g/
day), and 2 of 39 (5.13%) had acute kidney injury. In addition, serum C4 level
was 7.75  5.92 (range 4e29) mg/L, ANA titer was 194.36  130.50, and
eGFR was 91.64  29.09 (range 24.3e137) ml/min/1.73 m2. 18 cases
(46.15%) had positive anti-dsDNA. Student’s paired t-test analysis was used
for statistical evaluation.
Results: The serum C3 levels were below normal (35.78  14.06; range
17.5e63.8 mg/L) at baseline and continued to last (51.02  12.99; range
15.0e70.8 mg/L), though the last C3 levels were higher than the baseline
(P Z 0.001). In the 6th month, 26 cases (66.67%) had achieved complete
remission, 9 cases (23.08%) had partial remission, and 4 cases had no
response. During the 9e113th month, 19 cases (48.72%) had nephritis
relapse, and 9 cases (23.08%) had decreased eGFR dropping from
86.11  27.75 (range 49.3e116.5) ml/min/1.73 m2 to 35.92  24.1 (range
8.47e74.9) ml/min/1.73 m2 (P Z 0.001).
Conclusion: Persistence of low serum C3 level is associated with higher
relapse rate and influences prognosis in lupus.http://dx.doi.org/10.1016/j.hkjn.2015.08.148
